Dermatol. praxi. 2014;8(4):149-150

Nail psoriasis

MUDr.Gabriela Janoušková
Dermatovenerologické oddělení FN Motol

Psoriasis is a chronic inflammatory skin disease that affects 2–3% of population. Nail psoriasis occurs in up to 50% of psoriatic patiens.

Approximately 80% of patiens with psoriatic arthritis (PsA) have concurrent nail involvement. However, nail psoriasis is often overlooked

by physicians, despite a significant impact on patient´s quality of life.

Keywords: nail psoriasis, NAPSI, topical and systemic therapy

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janoušková G. Nail psoriasis. Dermatol. praxi. 2014;8(4):149-150.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rich P, Griffiths CHEM, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MCH, Guzzo C. Baseline nail disease in patiens with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231. Go to original source... Go to PubMed...
    2. Langley RG, Daudén E. Treatment and Management of Psoriasis with Nail Involvement: A Focus on Biologic Therapy. Dermatology 2010; 221 (suppl 1): 29-42. Go to original source... Go to PubMed...
    3. Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009; 23 (suppl 1): 15-21. Go to original source... Go to PubMed...
    4. Langley RG, Saurat JH, Reich K. Recommendations for treatment of nail psoriasis in patiens with moderate to severe psoriasis: a dermatology expert group consensus. J Eur Acad Dermatol Venereol 2012; 26: 373-381. Go to original source... Go to PubMed...
    5. Oram Y, Akkaya AD. Treatment of Nail Psoriasis: Common Concepts and New Trends. Dermatol Res Pract 2013; doi: 10.1155/2013/180496. Go to original source... Go to PubMed...
    6. Klaassen KMG, Van de Kerhof PCM, Pasch MC. Nail Psoriasis, the unknown burden of disease. J Eur Acad Dermatol Venereol 2014; doi: 10.1111/jdv.12368. Go to original source... Go to PubMed...
    7. De Jong EMGJ, Seegres BAMPA, Gulinck MK, Boezeman JBM, van de Kerhof PCM. Psoriasis of the nails associated with disability in a large number of patiens: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303. Go to original source... Go to PubMed...
    8. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K. Disease Severity, quality of life and health care in plaque-type psoriasis: multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372. Go to original source... Go to PubMed...
    9. Jiaravuthisan MM, Sasseville D, Vender RB, Murény F, Muhn CY. Psoriasis of the nail: anatomy, patology, clinical presentation, and review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27. Go to original source... Go to PubMed...
    10. Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212. Go to original source... Go to PubMed...
    11. Cassel SE, Bieber JD, Rich P, et al. The modified nail psoriasis Severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheum 2007; 34: 123-129. Go to PubMed...
    12. Tan ES, Chiny WS, Tey HL. Nail psoriasis: a review. Am J Clin Dermatol 2012; 13: 375-388. Go to original source... Go to PubMed...
    13. Wozel G, Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol 2008; 26: 448-459. Go to original source... Go to PubMed...
    14. Gregoriou S, Kalogeromitros D, Kosionis N, Gkouvi A, Rigopoulos D. Treatment options for nail psoriasis. Expert Rev Dermatol 2008; 3: 339-344. Go to original source...
    15. Baran R, Tosti A. Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation. J Dermatol Treatment 1999; 10(3): 201-204. Go to original source...
    16. Nakamura RC, Abreu LD, Duque-Estrada B, Tamler C, Leverone AP. Comparsion of nail lacquer clobetasol efficacy at 0,05%, 1%, and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study. An Bras Dermatol Sifil 2012; 87: 203-211. Go to original source... Go to PubMed...
    17. Tosti A, Piraccini BM, Cameli N, et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with bethametasone dipropionate and salicylic acid. Br J Dermatol 1998; 139: 655-659. Go to original source... Go to PubMed...
    18. Langley RG, Daudén E. Treatment and Management of Psoriasis with Nail Involvement: A Focus on Biologic Therapy. Dermatology 2010; 221(suppl 1): 29-42. Go to original source... Go to PubMed...
    19. Oram Y, Akkaya AD. Treatment of Nail Psoriasis: Common Concepts and New Trends. Dermatol Res Pract 2013; doi: 10. 1155/2013/180496.
    20. Lin Y-K, et al. Efficacy and safety of Indigo naturalis extract in oil (Lindiol) in treating nail psoriasis: A randomized, observer-blind, vehicle-controlled trial. Phytomedicine 2014; http://dx.doi.org/10.1016/j.phymed.2014.02.013. Go to original source... Go to PubMed...
    21. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM, Evaluation of the Efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009; 145(3): 269-271. Go to original source... Go to PubMed...
    22. Feliciani C, Zampetti A, Forleo P, et al. Nail psoriasis: Combined therapy with systemic cyclosporine and topical calcipotriol. J Cutan Med Surg 2004; 8: 122-125. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.